Rational AG free cash flow drops 35% on higher costs, despite sales growth

Rational AG reported mixed first-half 2025 results, with sales revenue up 4% to €606.2 million and net profit increasing to €120.3 million, alongside modest gains in gross profit and EBIT. However, the company's free cash flow plummeted 35% to €70.3 million, primarily due to higher tax payments, rising inventories and receivables, and reduced trade payables, signaling a significant deterioration in cash generation despite profit growth. While Rational maintained its full-year outlook for mid-single-digit sales growth and an EBIT margin near 26%, regional performance was varied, and the potential impact of new U.S. import tariffs remains an unquantified risk.

Analysis

Rational AG's first-half 2025 results present a notable divergence between profitability and cash generation. While the company reported a 4% increase in sales revenue to €606.2 million and a modest rise in net profit to €120.3 million, these figures are overshadowed by a severe 35% decline in free cash flow to €70.3 million. This cash flow deterioration is attributed to adverse working capital movements, including rising inventories and receivables, alongside higher tax payments. Despite an improved gross margin of 59%, driven by production efficiencies, the EBIT margin contracted slightly to 25.3% due to escalating operating costs, particularly a 22% surge in research and development expenses. Regional performance was mixed, with strong growth in North America (+11%) and Europe ex-Germany (+9%) offset by declines in Germany (-2%) and a significant 16% drop in Asia. Critically, the company's dividend payment of €170.6 million substantially exceeded its operating cash flow of €79.4 million for the period. While management maintained its full-year outlook for mid-single-digit sales growth and an EBIT margin near 26%, the combination of margin pressure, uneven geographic demand, and the unquantified risk of potential 15% U.S. import tariffs creates a cautious backdrop.

Key Decisions for Investors

• Investors should scrutinize the significant deterioration in free cash flow, as the wide gap between reported profit growth and actual cash generation is a primary concern for operational health.
• Monitor regional sales data closely, as weakness in key markets like Germany and Asia could undermine strong performance elsewhere and challenge the company's ability to meet its full-year guidance.
• Assess the sustainability of the dividend policy, given that the recent €170.6 million payout far exceeded the cash generated from operations, and consider the potential impact of the unquantified 15% U.S. tariff on future profitability.